[태그:] 영문
-

Genetic Checkpoints After Down Syndrome Diagnosis: What Clinicians Should Not Miss
Karyotype testing remains the gold-standard first-line diagnostic tool for confirming Down syndrome (DS). It reliably identifies Trisomy 21 and detects Robertsonian translocations, and in the majority of patients presenting with a typical phenotype, karyotyping alone is sufficient. That said, karyotyping has well-recognized structural limitations. Low-level mosaicism may go undetected with standard G-banding. Submicroscopic copy number…
-

3billion Showcases AI-Powered Variant Interpretation Innovation at ACMG 2026
BALTIMORE, MD – March 10, 2026 – 3billion (CEO Changwon Keum), a leader in AI-powered rare disease diagnostics, today announced its participation in the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting, taking place March 10 -14 in Baltimore, Maryland. The ACMG Annual Meeting is the world’s premier conference in…
-

Redefining Genetic Disease ‘Carriers’: Beyond Simple Transmitters to Real Health Impacts
📍Summary: Carriers of genetic diseases are not merely asymptomatic gene transmitters — depending on genetic and environmental factors, they can experience actual health symptoms, making personalized healthcare tailored to carriers a necessity. A recent article (February 15, 2026) challenged the conventional wisdom that carriers are ‘asymptomatic,’ drawing on specific diseases and carrier cases. Starting from…